Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Etanercept may not prevent alopecia areata from coming back.

Albendazole treatment for echinococcosis can cause serious side effects and requires close monitoring.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Azathioprine may be an effective treatment for severe hair loss.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.